133 related articles for article (PubMed ID: 24268019)
21. Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy.
Candrilli SD; Davis KL; Iyer S
J Pain Palliat Care Pharmacother; 2009; 23(3):231-41. PubMed ID: 19670020
[TBL] [Abstract][Full Text] [Related]
22. The economic burden of diagnosed opioid abuse among commercially insured individuals.
Rice JB; Kirson NY; Shei A; Enloe CJ; Cummings AK; Birnbaum HG; Holly P; Ben-Joseph R
Postgrad Med; 2014 Jul; 126(4):53-8. PubMed ID: 25141243
[TBL] [Abstract][Full Text] [Related]
23. Opioid Abuse: A Detailed Examination of Cost Drivers over a 24-Month Follow-up Period.
Scarpati LM; Kirson NY; Jia ZB; Wen J; Howard J
J Manag Care Spec Pharm; 2017 Nov; 23(11):1110-1115. PubMed ID: 29083966
[TBL] [Abstract][Full Text] [Related]
24. First Opioid Prescription and Subsequent High-Risk Opioid Use: a National Study of Privately Insured and Medicare Advantage Adults.
Zhang Y; Johnson P; Jeng PJ; Reid MC; Witkin LR; Schackman BR; Ancker JS; Bao Y
J Gen Intern Med; 2018 Dec; 33(12):2156-2162. PubMed ID: 30206790
[TBL] [Abstract][Full Text] [Related]
25. Cost and comorbidities associated with opioid abuse in managed care and Medicaid patients in the United Stated: a comparison of two recently published studies.
Ghate SR; Haroutiunian S; Winslow R; McAdam-Marx C
J Pain Palliat Care Pharmacother; 2010 Sep; 24(3):251-8. PubMed ID: 20718646
[TBL] [Abstract][Full Text] [Related]
26. Out-of-pocket costs and prescription reversals with oral linezolid.
Pasquale MK; Louder AM; Deminski MC; Chambers RB; Haider S
Am J Manag Care; 2013 Sep; 19(9):734-40. PubMed ID: 24304256
[TBL] [Abstract][Full Text] [Related]
27. Educational intervention for physicians to address the risk of opioid abuse.
Pasquale MK; Sheer RL; Mardekian J; Masters ET; Patel NC; Hurwitch AR; Weber JJ; Jorga A; Roland CL
J Opioid Manag; 2017; 13(5):303-313. PubMed ID: 29199396
[TBL] [Abstract][Full Text] [Related]
28. Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs.
White AG; LeCates J; Birnbaum HG; Cheng W; Roland CL; Mardekian J
J Opioid Manag; 2015; 11(3):199-210. PubMed ID: 25985805
[TBL] [Abstract][Full Text] [Related]
29. Analgesic opioid use in a health-insured epilepsy population during 2012.
Wilner AN; Sharma BK; Thompson AR; Krueger A
Epilepsy Behav; 2016 Apr; 57(Pt A):126-132. PubMed ID: 26949154
[TBL] [Abstract][Full Text] [Related]
30. Measuring attractiveness for abuse of prescription opioids.
Butler SF; Fernandez KC; Chang A; Benoit C; Morey LC; Black R; Katz N
Pain Med; 2010 Jan; 11(1):67-80. PubMed ID: 20002325
[TBL] [Abstract][Full Text] [Related]
31. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
McCarberg BH
Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
[TBL] [Abstract][Full Text] [Related]
32. Pain conditions ranked by healthcare costs for members of a national health plan.
Pasquale MK; Dufour R; Schaaf D; Reiners AT; Mardekian J; Joshi AV; Patel NC
Pain Pract; 2014 Feb; 14(2):117-31. PubMed ID: 23601620
[TBL] [Abstract][Full Text] [Related]
33. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse.
Rice JB; White AG; Birnbaum HG; Schiller M; Brown DA; Roland CL
Pain Med; 2012 Sep; 13(9):1162-73. PubMed ID: 22845054
[TBL] [Abstract][Full Text] [Related]
34. Healthcare costs associated with osteoarthritis in US patients.
Le TK; Montejano LB; Cao Z; Zhao Y; Ang D
Pain Pract; 2012 Nov; 12(8):633-40. PubMed ID: 22309128
[TBL] [Abstract][Full Text] [Related]
35. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
Amin AN; Jhaveri M; Lin J
Adv Ther; 2011 Oct; 28(10):907-26. PubMed ID: 21971681
[TBL] [Abstract][Full Text] [Related]
36. Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability.
Johnston SS; Alexander AH; Masters ET; Mardekian J; Semel D; Malangone-Monaco E; Riehle E; Wilson K; Sadosky A
J Occup Environ Med; 2016 Nov; 58(11):1087-1097. PubMed ID: 27820758
[TBL] [Abstract][Full Text] [Related]
37. Direct costs of opioid abuse in an insured population in the United States.
White AG; Birnbaum HG; Mareva MN; Daher M; Vallow S; Schein J; Katz N
J Manag Care Pharm; 2005; 11(6):469-79. PubMed ID: 15998164
[TBL] [Abstract][Full Text] [Related]
38. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
[TBL] [Abstract][Full Text] [Related]
39. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
[TBL] [Abstract][Full Text] [Related]
40. The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
Suehs BT; Davis CD; Alvir J; van Amerongen D; Pharmd NC; Joshi AV; Faison WE; Shah SN
Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):384-92. PubMed ID: 23687180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
